US 8961982
Modulation of developmental immune programming and protection against cardiovascular disease, diabetes, infectious diseases, and cancer
granted A61KA61K2039/55A61K2039/6081
Quick answer
US patent 8961982 (Modulation of developmental immune programming and protection against cardiovascular disease, diabetes, infectious diseases, and cancer) held by The Regents of the University of California expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K2039/55, A61K2039/6081, A61K39/0008, A61K39/0012